$4.19
-0.0600 (-1.41%)
At Close: Jul 31, 2026
Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD
08:50am, Tuesday, 12'th Sep 2023
Investigational New Drug (IND) submission to FDA on target for Q1 2024
Sign In
Buy SILO